Anandita Agrawal

Anandita Agrawal

Active Director Director DIN 02232236
DIN 02232236 First appointment Jul 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2008
Shareholding value •••• Premium profile

About Anandita Agrawal

Data last updated:

Anandita Agrawal is a Director at Lucare Pharma Private Limited (since 2008). The company operates in Pharma. Lucare Pharma Private Limited reported revenue of ₹6.28 Cr (FY 2025).

DIN 02232236
Primary Designation Director
Industry Pharma
First Appointment 04 Jul 2008
Oldest Company Age 18 yrs
Largest company Lucare Pharma Private Limited · ₹6.28 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lucare Pharma Private Limited U85110CT2008PTC020517
Director04 Jul 20082008₹6.28 Cr (FY 2025)Active

Board colleagues of Anandita Agrawal

Directorship timeline

Open interactive timeline →
Lucare Pharma Private Limited
Premium access

Shareholding and investment profile for Anandita Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anandita Agrawal

Anandita Agrawal currently holds 1 directorship: Lucare Pharma Private Limited (Director, since 04 Jul 2008, revenue ₹6.28 Cr (FY 2025)).

Anandita Agrawal was first appointed on 04 Jul 2008 as Director at Lucare Pharma Private Limited.

The current boards of Anandita Agrawal's companies include Bhola Shankar Agrawal (Lucare Pharma Private Limited), Manishkant Agrawal (Lucare Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available